home · filing · 0001213900-22-004031
8-K filed January 27, 2022, 6:59 PM ET
ticker NTRB
CIK 0001676047
other material
confidence high
sentiment positive
materiality 0.70
Nutriband expands AVERSA abuse-deterrent pipeline to include buprenorphine and methylphenidate
NutriBand Inc.
Adds AVERSA buprenorphine and AVERSA methylphenidate (ADHD) to pipeline; lead product AVERSA Fentanyl has $80-200M potential US sales.
CEO Gareth Sheridan and President Serguei Melnik sign 3-year employment agreements at $250k base salary; CFO Gerald Goodman at $210k.
Board grants stock options: Sheridan and Melnik each receive 20,000 shares at $5.34; 13 others get options at $4.85 or $5.34.
Irina Gram-Contulescu elected as new director; annual meeting also ratified auditor Sadler Gibb and approved 2021 Stock Option Plan.
By-laws amended to create CEO role and extend annual meeting window from 6 to 12 months after fiscal year-end.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Irina Gram-Contulescu
Director
Effective 2022-01-21
Filed January 27, 2022, 6:59 PM ET
Irina Gram-Contulescu, 34, was elected as a director of the Company at the January 21, 2022 stockholders meeting.
Role change
Serguei Melnik
Chairman of the Board
Effective 2022-01-21
Filed January 27, 2022, 6:59 PM ET
Serguei Melnik, a Board member, President and Secretary of the Company, was also appointed Chairman of the Board.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Irina Gram-Contulescu was elected as Director at NutriBand Inc..
Action elected
Role Director
Exact text from the filing
Irina Gram-Contulescu, 34, was elected as a director of the Company at the January 21, 2022 stockholders meeting.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Serguei Melnik was appointed as Chairman of the Board at NutriBand Inc..
Action appointed
Role Chairman of the Board
Exact text from the filing
Serguei Melnik, a Board member, President and Secretary of the Company, was also appointed Chairman of the Board.
View on SEC.gov
Source: SEC EDGAR
accession 0001213900-22-004031
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.